Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardiovascular Research Technologies (CRT) 2025
Start date: Mar 08, 2025 End date: Mar 11, 2025
Cardiovascular Research Technologies (CRT) 2025 will take place from Saturday March 8th to Tuesday March 11th at the Washington Hilton Hotel in Washington, DC.Cardiovascular Research Technologies (CRT) is a premier educational forum dedicated to the latest advancements in cardiovascular technology and procedures, tailored for physicians and healthcare professionals. CRT offers top-notch education… View more

Intervention
THT 2024
Start date: Mar 06, 2024 End date: Mar 04, 2024
The CardioVascular Research Foundation (CRF) proudly organizes Technology and Heart Failure Therapeutics (THT) 2024.This conference offers a unique perspective by uniting device- and technology-based therapies with drug-based approaches, effectively bridging gaps in current practices. Attendees can expect comprehensive updates on the status of treatments for heart failure, spanning drug and… View more

Heart Failure
Cardiovascular Research Technologies 2024
Start date: Mar 09, 2024 End date: Mar 12, 2024
Cardiovascular Research Technologies (CRT) is a premier educational platform delving into the forefront of cardiovascular technology and procedures, tailored for the discerning audience of physicians and healthcare professionals. This forum curates an exceptional educational experience, catering to interventional cardiologists, general cardiologists, cardiothoracic and vascular surgeons,… View more

Heart Failure
ACC.24: The TACTiC Trial
Author(s): Steven E Nissen Added: 1 year ago
ACC.24 — Investigator, Dr Steven Nissen (Cleveland Clinic, US) joins us onsite to discuss the findings of a trial designed to evaluate the extent to which participants could safely and effectively select, purchase and use rosuvastatin calcium 5mg for a 6-month trial period (NCT04964544).The TACTiC trial is a single-arm interventional, phase III self-selection and actual use study implementing a… View more

Digital Health

Prevention & Chronic Conditions
AHA 23: The ORFAN Study
Author(s): Charalambos Antoniades Added: 2 years ago
AHA 23 — In this brief interview, we are joined by Prof Charalambos Antoniades (Oxford University, UK) to discuss the ORFAN trial, sponsored by the University of Oxford.ORFAN is a prospective, multicenter, observational study that collected CT scans, biological material and outcomes data to develop and validate biomarkers of cardiometabolic risk. The registry included 250000 unselected… View more

Digital Health

Prevention & Chronic Conditions
Ethical and Regulatory Frameworks Post-AI Act in Clinical Research
Author(s): Andrea Barucci , Valentina Colcelli , Salvatore De Masi , et al Added: 2 days ago

Digital Health

Guidelines & Statements
Yu Ren

Author

ESC 25: ESVM Guidelines on Interventional Treatment of VTE
Author(s): Oliver Schlager Added: 4 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more

Guidelines & Statements

Intervention
Research Area(s) / Expertise:

Coronary Physiology

 Job title: Consultant Interventional Cardiologist and Honorary Senior Lecturer
Dr De Silva is a consultant interventional cardiologist, at St. Thomas’ Hospital and Honorary Senior Lecturer at King's College London. Dr De Silva’s clinical focus is on undertaking complex, high-risk PCI, with a particular interest in education, and methods of refining and improving quality and procedural efficiency in PCI practice. He remains dedicated to adopting and utilising new technology… View more